Rafael Morales-Barrera

8PUBLICATIONS
119CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Feb 12, 2026
Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma.

Failah Mohamed Lamin Mohamed Mouloud, Rafael Morales-Barrera, Inés María de Torres

|Aug 07, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier

|Oct 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.

Aude Fléchon, Rafael Morales-Barrera, Thomas Powles

|Aug 31, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).

Alexandra Drakaki, Thomas Powles, Aristotelis Bamias

|Jun 10, 2023
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.

Nataliya Mar, Yousef Zakharia, Alejandro Falcon

Pageof 2

Frequent Collaborators

2 joint publications

Silke Gillessen

2 joint publications

Aude Fléchon

2 joint publications

Florence Joly Lobbedez

2 joint publications

Thomas Powles